Electromed, Inc. (ELMD) Operating Margin
- Operating margin · 12 months: Value 18.82%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 18.82% | Operating income / revenue. Period ending 2026-06-30. $13.88M ÷ $73.78M × 100 ≈ 18.82% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 13.88M USD | Operating Income (Loss) |
| Revenue | 73.78M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 1.31M USD | Research and Development Expense |
| Selling, general and administration | 42.75M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.88M | $73.78M | (m) | $1.31M | $42.75M | 18.82% |
| 2026-03-31 | $13.10M | $71.75M | (m) | $1.29M | $41.90M | 18.25% |
| 2025-12-31 | $11.47M | $68.86M | (m) | $1.20M | $41.20M | 16.66% |
| 2025-09-30 | $10.39M | $66.22M | (m) | $1.07M | $40.21M | 15.69% |
| 2025-06-30 | $9.66M | $64.00M | (m) | $996.00K | $39.31M | 15.09% |
| 2025-03-31 | $8.96M | $61.44M | (m) | $870.00K | $37.82M | 14.58% |
| 2024-12-31 | $8.66M | $59.63M | (m) | $760.00K | $36.38M | 14.52% |
| 2024-09-30 | $8.38M | $57.06M | (m) | $616.00K | $34.73M | 14.68% |
| 2024-06-30 | $6.58M | $54.72M | (m) | $656.00K | $34.49M | 12.03% |
| 2024-03-31 | $5.74M | $53.50M | (m) | $778.00K | $34.36M | 10.73% |
| 2023-12-31 | $5.09M | $51.69M | (m) | $777.00K | $33.68M | 9.86% |
| 2023-09-30 | $4.11M | $49.73M | (m) | $824.00K | $32.76M | 8.26% |
| 2023-06-30 | $4.01M | $48.07M | (m) | $916.00K | $31.59M | 8.34% |
| 2023-03-31 | $3.01M | $45.72M | (m) | $933.00K | $30.25M | 6.58% |
| 2022-12-31 | $2.68M | $43.80M | (m) | $1.10M | $29.09M | 6.11% |
| 2022-09-30 | $2.48M | $42.32M | (m) | $1.28M | $28.32M | 5.86% |
| 2022-06-30 | $2.97M | $41.66M | (m) | $1.36M | $27.11M | 7.13% |
| 2022-03-31 | $3.13M | $39.86M | (m) | $1.37M | $25.76M | 7.85% |
| 2021-12-31 | $2.51M | $38.51M | (m) | $1.44M | $25.27M | 6.52% |
| 2021-09-30 | $3.02M | $37.75M | (m) | $1.62M | $24.23M | 7.99% |
| 2021-06-30 | $3.14M | $35.76M | (m) | $1.72M | $22.44M | 8.78% |
| 2021-03-31 | $3.78M | $33.16M | (m) | $1.81M | $21.29M | 11.39% |
| 2020-12-31 | $4.45M | $33.12M | (m) | $1.80M | $20.52M | 13.43% |
| 2020-09-30 | $4.43M | $32.17M | (m) | $1.43M | $20.05M | 13.78% |
| 2020-06-30 | $5.12M | $32.47M | (m) | $1.05M | $19.94M | 15.76% |
| 2020-03-31 | $5.31M | $34.20M | (m) | $740.90K | $20.23M | 15.52% |
| 2019-12-31 | $4.86M | $32.86M | (m) | $519.70K | $19.88M | 14.78% |
| 2019-09-30 | $3.97M | $32.33M | (m) | $614.06K | $20.07M | 12.27% |
| 2019-06-30 | $2.82M | $31.30M | (m) | $583.31K | $20.45M | 9.00% |
| 2019-03-31 | $2.89M | $30.96M | (m) | $558.11K | $20.98M | 9.35% |
| 2018-12-31 | $3.01M | $30.72M | (m) | $430.01K | $20.93M | 9.80% |
| 2018-09-30 | $3.11M | $29.67M | (m) | $248.92K | $20.35M | 10.48% |
| 2018-06-30 | $3.01M | $28.70M | (m) | $251.44K | $19.60M | 10.48% |
| 2018-03-31 | $2.93M | $27.73M | (m) | $234.74K | $18.96M | 10.57% |
| 2017-12-31 | $3.48M | $27.31M | (m) | $272.69K | $18.08M | 12.76% |
| 2017-09-30 | $3.44M | $26.70M | (m) | $316.62K | $17.42M | 12.90% |
| 2017-06-30 | $3.57M | $25.86M | (m) | $596.88K | $16.40M | 13.80% |
| 2017-03-31 | $2.59M | $24.28M | (m) | $729.60K | $15.73M | 10.68% |
| 2016-12-31 | $2.29M | $23.65M | (m) | $733.40K | $15.35M | 9.70% |
| 2016-09-30 | $2.81M | $23.54M | (m) | $689.69K | $14.84M | 11.95% |
| 2016-06-30 | $3.11M | $22.99M | (m) | $380.39K | $14.39M | 13.52% |
| 2016-03-31 | $2.98M | $22.50M | (m) | $261.49K | $13.89M | 13.24% |
| 2015-12-31 | $2.30M | $21.02M | (m) | $255.37K | $13.11M | 10.94% |
| 2015-09-30 | $1.50M | $19.64M | (m) | $281.93K | $12.39M | 7.62% |
| 2015-06-30 | $1.31M | $19.41M | (m) | $315.65K | $11.97M | 6.75% |
| 2015-03-31 | $1.27M | $18.82M | (m) | $298.25K | $11.53M | 6.72% |
| 2014-12-31 | $990.77K | $18.22M | (m) | $323.13K | $11.14M | 5.44% |
| 2014-09-30 | $234.59K | $16.84M | (m) | $332.22K | $11.01M | 1.39% |
| 2014-06-30 | $-740.59K | $15.49M | (m) | $466.06K | $10.91M | -4.78% |
| 2014-03-31 | $-1.54M | $14.89M | (m) | $696.49K | $10.92M | -10.37% |
| 2013-12-31 | $-2.02M | $14.14M | (m) | $694.78K | $11.32M | -14.30% |
| 2013-09-30 | $-2.31M | $14.49M | (m) | $711.29K | $11.58M | -15.93% |
| 2013-06-30 | $-1.83M | $15.10M | (m) | $603.38K | $11.67M | -12.10% |
| 2013-03-31 | $-1.56M | $15.67M | (m) | $527.01K | $12.03M | -9.94% |
| 2012-12-31 | $-638.05K | $17.24M | (m) | $663.78K | $11.90M | -3.70% |
| 2012-09-30 | $57.51K | $18.18M | (m) | $804.87K | $12.03M | 0.32% |
| 2012-06-30 | $606.34K | $19.52M | (m) | $920.77K | $12.62M | 3.11% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $1.87M | $19.00M | (m) | $1.03M | $10.87M | 9.84% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |